- Home
- BLZE vs GOSS Comparison
BLZE vs GOSS Comparison
Compare BLZE & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLZE
- GOSS
- Stock Information
- Founded
- BLZE 2007
- GOSS 2015
- Country
- BLZE United States
- GOSS United States
- Employees
- BLZE N/A
- GOSS N/A
- Industry
- BLZE Computer Software: Prepackaged Software
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- BLZE Technology
- GOSS Health Care
- Exchange
- BLZE Nasdaq
- GOSS Nasdaq
- Market Cap
- BLZE 545.4M
- GOSS 501.2M
- IPO Year
- BLZE 2021
- GOSS 2019
- Fundamental
- Price
- BLZE $4.96
- GOSS $2.72
- Analyst Decision
- BLZE Strong Buy
- GOSS Strong Buy
- Analyst Count
- BLZE 6
- GOSS 6
- Target Price
- BLZE $9.50
- GOSS $8.60
- AVG Volume (30 Days)
- BLZE 771.9K
- GOSS 2.9M
- Earning Date
- BLZE 11-06-2025
- GOSS 11-05-2025
- Dividend Yield
- BLZE N/A
- GOSS N/A
- EPS Growth
- BLZE N/A
- GOSS N/A
- EPS
- BLZE N/A
- GOSS N/A
- Revenue
- BLZE $141,859,000.00
- GOSS $44,051,000.00
- Revenue This Year
- BLZE $16.78
- GOSS N/A
- Revenue Next Year
- BLZE $13.99
- GOSS $16.11
- P/E Ratio
- BLZE N/A
- GOSS N/A
- Revenue Growth
- BLZE 15.73
- GOSS N/A
- 52 Week Low
- BLZE $3.94
- GOSS $0.66
- 52 Week High
- BLZE $10.86
- GOSS $3.60
- Technical
- Relative Strength Index (RSI)
- BLZE 19.62
- GOSS 58.19
- Support Level
- BLZE $10.29
- GOSS $2.21
- Resistance Level
- BLZE $10.86
- GOSS $2.71
- Average True Range (ATR)
- BLZE 0.59
- GOSS 0.16
- MACD
- BLZE -0.53
- GOSS 0.05
- Stochastic Oscillator
- BLZE 0.75
- GOSS 88.07
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.